Generic Drugs: Guidelines for Bioequivalence Studies - Pushpendra Kumar Vishwakarma - Libros - VDM Verlag Dr. Müller - 9783639343779 - 2 de junio de 2011
En caso de que portada y título no coincidan, el título será el correcto

Generic Drugs: Guidelines for Bioequivalence Studies


Recibe un correo electrónico cuando el artículo esté disponible
¿Tienes un perfil? Iniciar sesión
Añadir a tu lista de deseos de iMusic

A generic drug (generic drugs, short: generics) is a drug which is produced and distributed without patent protection. The generic drug may still have a patent on the formulation but not on the active ingredient. A generic must contain the same active ingredients as the original formulation. According to the U. S. Food and Drug Administration (FDA), generic drugs are identical or bioequivalent to the brand name counterpart with respect to pharmacokinetic and pharmacodynamic properties. By extension, therefore, generics are identical in dose, strength, route of administration, safety, efficacy, and intended use. In most cases, generic products are available once the patent protections afforded to the original developer have expired. When generic products become available, the market competition often leads to substantially lower prices for both the original brand name product and the generic forms. The time it takes a generic drug to appear on the market varies.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 2 de junio de 2011
ISBN13 9783639343779
Editores VDM Verlag Dr. Müller
Páginas 148
Dimensiones 150 × 9 × 226 mm   ·   226 g
Lengua Inglés  

Mas por Pushpendra Kumar Vishwakarma

Mostrar todo

Mere med samme udgiver